Quality of Life in Danish Blood Donors Treated for Superficial Fungal Infection

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 254 KB, PDF-dokument

OriginalsprogEngelsk
Artikelnummeradv00617
TidsskriftActa Dermato-Venereologica
Vol/bind101
Udgave nummer12
ISSN0001-5555
DOI
StatusUdgivet - 2021

Bibliografisk note

Funding Information:
PLA and ICL received support from Naestved, Slagelse and Ringsted Hospitals’Research Fund, and PLAreceived a PhD grant

Funding Information:
The Danish Blood Donor Study is funded by: The Danish Coun-cil for Independent Research ? Medical Sciences (grant number 09-069412); The Danish Administrative Regions (http://www. regioner.dk); The A. P. M?ller Foundation for the Advancement of Medical Science; The Danish Bio-and Genome Bank (http:// www.regioner.dk/rbgben). None of the funders had any influence on study design, data collection and analysis, decision to publish, or preparation of this manuscript. Oral and written informed consent was obtained from all participants. The DBDS (1-10-72-95-13) and DBDSII (SJ-740) are approved by the Scientific Ethical Committees in Central Denmark Region and Region Zealand, respectively. The DBDS was approved by the Danish Data Protection Agency (P-2019-99). This study was conducted in accordance with the principles of the Declaration of Helsinki. PLA and ICL received support from Naestved, Slagelse and Ringsted Hospitals? Research Fund, and PLA received a PhD grant from LEO Foundation (grant number LF18002). DMLS participated in advisory board meeting by AbbVie, Janssen, Sanofi, Leo Pharma and received honoraria. DMLS also received speaker?s honoraria and/or grants from the following companies: Abbvie, Desitin, Pfizer, Galderma, Novartis and Leo Pharma during the last 5 years. GBJ reports grants from Leo Research Foundation, during the conduct of the study; personal fees from Abbvie, personal fees from Chemocentryx, personal fees from Kymera, personal fees from Leo Pharma, personal fees from Coloplast, grants and personal fees from Novartis, grants and personal fees from UCB, grants and personal fees from Inflarx, grants from Janssen-Cilag, grants from Serono, grants from Regeneron, outside the submitted work. OBP has no conflicts of interests to disclose.

Funding Information:
The Danish Blood Donor Study is funded by: The Danish Council for Independent Research – Medical Sciences (grant number 09-069412); The Danish Administrative Regions (http://www. regioner.dk); The A. P. Møller Foundation for the Advancement of Medical Science; The Danish Bio-and Genome Bank (http:// www.regioner.dk/rbgben). None of the funders had any influence on study design, data collection and analysis, decision to publish, or preparation of this manuscript.

ID: 305535111